Get more replies from employers
Send a job-specific resume in minutes.
Roth Capital Partners seeks an Equity Research Associate to support a Senior Biotech Research Analyst focused on emerging SMID-cap firms in healthcare, particularly brain disorders and rare indications.
You will be responsible for research, data collection, and statistical studies on industries and securities, with on-the-job training to master investment analysis and reporting.
Roth Capital Partners, LLC is a relationship-driven investment bank focused on serving growth companies and their investors. In addition to capital markets and M&A advisory services, our full-service platform provides a variety of capital markets solutions, including high impact equity research, macroeconomic perspectives, institutional sales and trading, technical insights, derivatives strategies and corporate access. Headquartered in Newport Beach, California, Roth is a privately held, employee-owned organization and maintains offices throughout the U.S.
Roth is looking to add an Equity Research Associate to support a Senior Biotech Research Analyst focusing on emerging SMID-cap firms in healthcare, particularly brain disorders and rare indications. The Equity Research Associate is responsible for research, client support, data collection, and statistical studies on industries and individual companies and their securities. Through training and on-the-job experience, the Research Associate learns the techniques and develops the skills necessary to research and analyze investment securities and to prepare and present investment recommendations.
About the Team: The candidate will report to a Senior Biotech Research Analyst who received his Ph.D. in Medicinal Chemistry from The University of Illinois at Chicago and conducted several years of Postdoctoral research at leading institutions, including Northwestern University (14 peer-reviewed publications/industry articles and 1 patent). In addition, he has seven years of Biotech Equity Research experience covering a broad range of indications, therapeutic modalities and firm sizes. At Roth, he covers 15 companies with a focus on neurology, neurodegeneration, neuromuscular and rare indications.
70,000 base + commensurate on experience
Annual discretionary bonus
Powered by JazzHR